Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LINCOLN PHAR vs KILITCH DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LINCOLN PHAR KILITCH DRUGS LINCOLN PHAR/
KILITCH DRUGS
 
P/E (TTM) x 13.9 45.2 30.7% View Chart
P/BV x 2.4 4.0 60.9% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 LINCOLN PHAR   KILITCH DRUGS
EQUITY SHARE DATA
    LINCOLN PHAR
Mar-23
KILITCH DRUGS
Mar-23
LINCOLN PHAR/
KILITCH DRUGS
5-Yr Chart
Click to enlarge
High Rs380218 174.0%   
Low Rs255121 210.2%   
Sales per share (Unadj.) Rs254.889.6 284.3%  
Earnings per share (Unadj.) Rs36.45.3 684.6%  
Cash flow per share (Unadj.) Rs41.07.6 539.4%  
Dividends per share (Unadj.) Rs1.500-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs250.993.9 267.3%  
Shares outstanding (eoy) m20.0315.58 128.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.21.9 65.7%   
Avg P/E ratio x8.731.9 27.3%  
P/CF ratio (eoy) x7.722.4 34.7%  
Price / Book Value ratio x1.31.8 69.9%  
Dividend payout %4.10-   
Avg Mkt Cap Rs m6,3582,646 240.3%   
No. of employees `000NANA-   
Total wages/salary Rs m932117 793.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,1031,396 365.6%  
Other income Rs m22529 770.2%   
Total revenues Rs m5,3281,425 373.8%   
Gross profit Rs m892177 503.1%  
Depreciation Rs m9236 258.1%   
Interest Rs m2051 39.9%   
Profit before tax Rs m1,005120 836.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m27637 739.0%   
Profit after tax Rs m72983 880.1%  
Gross profit margin %17.512.7 137.6%  
Effective tax rate %27.431.1 88.4%   
Net profit margin %14.35.9 240.8%  
BALANCE SHEET DATA
Current assets Rs m3,9111,264 309.4%   
Current liabilities Rs m962689 139.6%   
Net working cap to sales %57.841.2 140.2%  
Current ratio x4.11.8 221.6%  
Inventory Days Days128163 78.6%  
Debtors Days Days9751,419 68.7%  
Net fixed assets Rs m2,454911 269.3%   
Share capital Rs m200156 128.5%   
"Free" reserves Rs m4,8241,307 369.2%   
Net worth Rs m5,0251,462 343.6%   
Long term debt Rs m00-   
Total assets Rs m6,3652,175 292.6%  
Interest coverage x50.53.4 1,501.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 124.9%   
Return on assets %11.86.1 191.6%  
Return on equity %14.55.7 256.2%  
Return on capital %20.411.7 174.5%  
Exports to sales %57.40-   
Imports to sales %2.00-   
Exports (fob) Rs m2,931NA-   
Imports (cif) Rs m100NA-   
Fx inflow Rs m2,931602 486.8%   
Fx outflow Rs m100161 62.3%   
Net fx Rs m2,831441 641.4%   
CASH FLOW
From Operations Rs m39326 1,518.3%  
From Investments Rs m-36679 -463.0%  
From Financial Activity Rs m-45-7 628.6%  
Net Cashflow Rs m-1998 -19.2%  

Share Holding

Indian Promoters % 49.5 69.2 71.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 0.0 -  
FIIs % 3.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.5 30.8 164.0%  
Shareholders   31,375 9,525 329.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LINCOLN PHAR With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on LINCOLN PHAR vs KILITCH DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

LINCOLN PHAR vs KILITCH DRUGS Share Price Performance

Period LINCOLN PHAR KILITCH DRUGS S&P BSE HEALTHCARE
1-Day 1.67% -2.40% -0.44%
1-Month 1.01% -5.41% -0.19%
1-Year 54.58% 102.79% 53.63%
3-Year CAGR 28.89% 49.57% 14.59%
5-Year CAGR 27.28% 13.96% 19.77%

* Compound Annual Growth Rate

Here are more details on the LINCOLN PHAR share price and the KILITCH DRUGS share price.

Moving on to shareholding structures...

The promoters of LINCOLN PHAR hold a 49.5% stake in the company. In case of KILITCH DRUGS the stake stands at 69.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of LINCOLN PHAR and the shareholding pattern of KILITCH DRUGS.

Finally, a word on dividends...

In the most recent financial year, LINCOLN PHAR paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 4.1%.

KILITCH DRUGS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of LINCOLN PHAR, and the dividend history of KILITCH DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9% Sensex Today Ends 189 Points Lower | IT Stocks Drag | REC Rallies 10%, Hitachi Energy 9%(Closing)

After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.